✦ LIBER ✦

Comparison of acarbose versus glibenclamide as an adjunct to bedtime insulin in patients with type-2 diabetes

✍ Scribed by SalemD. Al-Swsaidan; SamiM. Bashi; AhmedA. Al-Arfaj; SalehJ. Al-Jaser

Book ID: 117369808
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 137 KB
Volume: 50
Category: Article
ISSN: 0168-8227
DOI: 10.1016/s0168-8227(00)81710-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Withdrawal of insulin therapy after adju

Withdrawal of insulin therapy after adjunctive treatment with acarbose in a patient with Type 2 diabetes mellitus

✍ Bennett, SMA ;Stewart, MW 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB

## Abstract Acarbose has been shown to reduce post‐prandial hyperglycaemia and improve glycaemic control in patients with Type 2 diabetes mellitus. We report its use as an adjunct to established insulin therapy in a 64 year old man with Type 2 diabetes mellitus and secondary failure to treatment wi

Effects of a combination of bedtime inte

Effects of a combination of bedtime intermediate-acting insulin and glibenclamide in type 2 (non-insulin-dependent) diabetic patients with secondary failure to respond to oral hypoglycaemic agents

✍ M. Krempf; T. Godeau; S. Ranganathan; P. Blanchard; P. Ritz; B. Charbonnel 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 603 KB

The effect of a subcutaneous injection of an intermediate-acting insulin at bedtime combined with glibenclamide has been evaluated in 16 non-insulin-diabetic patients with secondary failure to respond to oral agents. The patients showed poor metabolic control (HbA1 greater than 11%) after two months

Pramlintide as an Adjunct to Basal Insul

Pramlintide as an Adjunct to Basal Insulin: Effects on Glycemic Control and Weight in Patients with Type 2 Diabetes Mellitus

✍ Cameron W. Lush; Tamara Darsow; Bei Zhang; Gayle Lorenzi; Juan P. Frias 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 577 KB

Effects on Blood Pressure of the α-Gluco

Effects on Blood Pressure of the α-Glucosidase Inhibitor Acarbose Compared with the Insulin Enhancer Glibenclamide in Patients with Hypertension and Type 2 Diabetes Mellitus

✍ Prof Julian H. Rosenthal, Herbert Mauersberger 📂 Article 📅 2002 🏛 Springer International Publishing AG 🌐 English ⚖ 124 KB

Safety and efficacy of repaglinide in co

Safety and efficacy of repaglinide in combination with metformin and bedtime NPH insulin as an insulin treatment regimen in type 2 diabetes

✍ Miguel Civera; Angel Merchante; María Salvador; Javier Sanz; Isidoro Martínez 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 238 KB

Effects of the combination of insulin an

Effects of the combination of insulin and glibenclamide in Type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral hypoglycaemic agents

✍ S. Stenman; P. -H. Groop; C. Saloranta; K. J. Tötterman; F. Fyhrqvist; L. Groop 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 971 KB

The effects of combined insulin and sulfonylurea therapy on glycaemic control and B-cell function was studied in 15 Type 2 (non-insulin-dependent) diabetic patients who had failed on treatment with oral hypoglycaemic agents. The patients were first treated with insulin alone for four months. Five pa